GGrantIndex
Sort

4,870 grants matching glp 1

Metabolic effects of non-nutritive sweeteners

$267,615
Kristina Rother · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK

Biorepository, Pathology, and Immune Monitoring Core

$267,207
Kent J. Weinhold · Duke University · P50 · FY2020 · CA

Aging And The Pancreas

$266,929
Josephine Egan · National Institute On Aging · ZIA · FY2023 · AG

IGF::OT::IGF "Multi-Dose Rodent Pharmacokinetic Assessment"

$266,658
Rose Hood · Sri International · N01 · FY2013 · DA

Enhanced Local Lymph Node Assay Using Flow Cytometry

$266,597
Mb Research Laboratories, Inc. · R44 · FY2004 · ES

Molecular Basis of Antidiabetogenic Hormone Action

$266,562
George G Holz · Upstate Medical University · R01 · FY2010 · DK

3 UTR CONTROL OF TRA-2 TRANSLATION IN C ELEGANS

$266,295
University Of Wisconsin Madison · R01 · FY2001 · GM

Core C: Product Analysis Core

$266,249
Maciej Lukasz Goniewicz · Roswell Park Cancer Institute Corp · U54 · FY2020 · CA

Human Rhodopsin-ADRP studies

$265,872
Artur V Cideciyan · University Of Pennsylvania · R24 · FY2016 · EY

Biomarker Reference Laboratory

$265,847
Daniel W Chan · Johns Hopkins University · U2C · FY2025 · CA

Core--Morphology

$265,784
University Of North Carolina Chapel Hill · P01 · FY2002 · HL

Core C: Product Analysis Core

$264,919
Maciej Lukasz Goniewicz · Roswell Park Cancer Institute Corp · U54 · FY2019 · CA

Pediatric Type 1 diabetes: Intervention Trials With Glucagon Suppressors

$264,749
Rubina A Heptulla · Baylor College Of Medicine · R01 · FY2008 · DK

Mechanisms of Intestinal Stem Cell Expansion Following Resection

$264,347
Michael A Helmrath · Cincinnati Childrens Hosp Med Ctr · R01 · FY2011 · DK

LIRAGLUTIDE AS ADDITIONAL TREATMENT IN PATIENTS WITH TYPE 1 DIABETES MELLITUS

$264,173
Paresh Dandona · State University Of New York At Buffalo · R01 · FY2013 · DK

ROLE OF PRESENILIN IN NOTCH AND APP MATURATION

$264,086
Washington University · R01 · FY2000 · AG

Pediatric Type 1 diabetes: Intervention Trials With Glucagon Suppressors

$263,956
Rubina A Heptulla · Baylor College Of Medicine · R01 · FY2009 · DK

Molecular Pathology Shared Resource

$263,847
Dan Theodorescu · University Of Colorado Denver · P30 · FY2018 · CA

REDUCIBLE POLYAMIDO ETHYLENIMINE FOR GLP-1 PLASMID DELIVERY

$263,375
Sung Wan Kim · University Of Utah · R01 · FY2009 · DK

RP1: rVSV Vectored Vaccine to Treat Ebola and Marburg Infection

$263,375
John H Eldridge · University Of Texas Med Br Galveston · U19 · FY2018 · AI

Repolarization of Activated Th1 Cells: a Novel Means to Treat IBD

$263,034
Kanneganti Murthy · Radikal Therapeutics, Inc. · R43 · FY2011 · AI

REDUCIBLE POLYAMIDO ETHYLENIMINE FOR GLP-1 PLASMID DELIVERY

$262,501
Sung Wan Kim · University Of Utah · R01 · FY2008 · DK

Supplemental Grant Request to existing 5U01AG053247 - 03 - TK/PK Assay Analysis and Development

$262,500
Eric Siemers · Acumen Pharmaceuticals, Inc. · U01 · FY2020 · AG

Pediatric Pharmacology Research Unit Network

$262,494
Jeffrey Scott Barrett · Children'S Hosp Of Philadelphia · U10 · FY2009 · HD

Mechanisms of Intestinal Stem Cell Expansion Following Resection

$262,423
Michael A Helmrath · Cincinnati Childrens Hosp Med Ctr · R01 · FY2012 · DK